Prevalence of potentially harmful multidrug interactions on medication lists of elderly ambulatory patients

It has been hypothesized that polypharmacy may increase the frequency of multidrug interactions (MDIs) where one drug interacts with two or more other drugs, amplifying the risk of associated adverse drug events (ADEs).